Y-Intercept (HK)’s Immunome IMNM Stock Holding History

Y-Intercept (HK)’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,948	Closed	-$349K	–	1931
2026 Q1	$349K	Buy	+15,948	New	+$355K	0.01%	1343
2025 Q3	–	Sell	-85,227	Closed	-$793K	–	1781
2025 Q2	$793K	Buy	+85,227	New	+$699K	0.02%	1048

Other funds holding IMNM

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Y-Intercept (HK)'s IMNM Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Immunome (IMNM) in Q2 2026, closing a stake of 15,948 shares — an estimated $349K sold.

Y-Intercept (HK) first reported a position in IMNM in Q2 2025 and held it in 2 quarters. The position peaked at $793K in Q2 2025. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Y-Intercept (HK) reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 15,948 Immunome shares in Q2 2026, an estimated $349K.
Y-Intercept (HK) first reported a position in Immunome in Q2 2025 and held it in 2 quarters.
Y-Intercept (HK)'s Immunome position peaked at $793K in Q2 2025.
7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.